PHIL PHARMAWEALTH, INC. is a 100% Filipino-owned company licensed by the Securities and Exchange Commission and the Food and Drug Administration to import and distribute medical devices, disposables, and instruments, as well as all forms of finished pharmaceutical products. These products may come in the form of capsules, tablets, syrups, suspensions, ointments, cream gels, aerosols, inhalation anesthetics, and parenteral products.
The company was established and incorporated on the 10th of February 1993 in response to the government's call for existing and newly-established pharmaceutical companies to actively participate in the implementation and fulfillment of a new health policy contained in the Generics Act of 1988. The aim of this policy is to alleviate the burden of the sick and poverty-stricken majority by encouraging the offering of affordable and quality medicines.
From an initially insignificant start, PHIL. PHARMAWEALTH, INC. has managed to overcome the challenge of registering and importing its own product lines, which now number 300. While many pharmaceutical companies focus on the manufacture and distribution of oral preparations, PHIL PHARMAWEALTH, INC. has chosen to be unique in its marketing and social goals by establishing a niche in life-saving products: INJECTIONS.
Blessed with a young and dynamic management team and with over 100 rank and file employees, the well-equipped and wisdom-guided force—indeed, the entire institution—hopes to achieve yet another phenomenal milestone that would cement the company's objective of becoming an unquestionably recognized National Pharmaceutical Company. This is particularly challenging in an industry where competition is fierce and a good reputation is hard-earned.
Today, PHIL PHARMAWEALTH, INC. is the largest Filipino importer of parenteral products, offering the widest range of formulations including cephalosporins, penicillins and derivatives, aminoglycosides, anesthetic agents, antipsychotic agents, bronchodilators, and uterine stimulants.
The establishment and operation of the company's manufacturing facility in San Pablo City, Laguna, known as SINGAPORE PHARMAWEALTH LIFESCIENCES INC., is a concrete response from PHIL PHARMAWEALTH, INC. to the government's call for the private sector to achieve global competitiveness. Operating under the theme "Opening the Gateway to Competitive and Quality Injectables," SINGAPORE PHARMAWEALTH LIFESCIENCES INC. aims to capitalize on the inexorable march towards globalization and the dismantling of trade barriers. Their goal is to attain a significant position in pharmaceutical manufacturing in the Philippines, demonstrating their commitment to producing competitive and high-quality injectable products.